Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Adrenocortical carcinoma
Trial Status:  Active
Results 1-25 of 32 for your search:
Start Over
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2412, NCT01794793
Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia
Phase: Phase III, Phase II
Type: Diagnostic
Status: Approved-not yet active
Age: 30 and over
Sponsor: Other
Protocol IDs: KS8-341, 2012-003604-13, NCT02010957
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: EudraCT 2007-007262-38, NCT00777244
LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
Phase: Phase III
Type: Screening
Status: Active
Age: 5 to 71
Sponsor: Other
Protocol IDs: CSET2011/1748, NCT01464086
Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011/1810, NCT01504555
Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Phase: Phase II, Phase I
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 93-102, NCT00579163
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BBI608-201, NCT01325441
Interleukin 13 PE for Adults With Advanced Cancers
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130046, 13-C-0046, NCT01766635
Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0882, NCI-2015-00042, NCT02239900
MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 76,770, NCT00252174
Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EudraCT 2008-000759-91, NCT00786110
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months and over
Sponsor: Other
Protocol IDs: CDR0000066485, BC-AD-2, NCT00003453
Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130114, 13-C-0114, NCT01833832
Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and over
Sponsor: Other
Protocol IDs: 09-090, NCT01099644
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ATR-101-001, NCT01898715
Study of Adrenal Gland Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 3 to 70
Sponsor: NICHD
Protocol IDs: 000160, 00-CH-0160, NCT00005927
German Adrenocortical Carcinoma Registry
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Wue-ACC-R-86-03, NCT00453674
Evaluation of Side Effects of Mitotane
Phase: No phase specified
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Wue-ACC-Mitotane, NCT00568139
Adrenal Tumors - Pathogenesis and Therapy
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: Wue-Adrenal-Tumors-92/2002, NCT00669266
International Pediatric Adrenocortical Tumor Registry
Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: IPACTR, NCT00700414
Anesthesia Management of Retroperitoneal Adrenalectomies
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: retroper adrenal, NCT00894335
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 7 and over
Sponsor: NCI
Protocol IDs: 090242, 09-C-0242, NCT01005654
Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010/297, NCT01246739
Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-A00705-34, 2010 08, NCT01284829
Start Over